US Map / Iowa
State IA

Clinical Trials in Iowa

Iowa is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Iowa and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 118 actively recruiting studies with Iowa sites out of 118 registered in total. The busiest research areas in Iowa are Acute Myeloid Leukemia, Breast Cancer, COPD. Leading sponsors running trials in the state include SWOG Cancer Research Network, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology. By stage, Iowa trials break down as Phase 1 (17), Phase 2 (30), Phase 3 (44), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
118
Recruiting Now
118
← Back to US Map
Top Conditions in Iowa
Acute Myeloid Leukemia (4)Breast Cancer (3)COPD (2)SLE (Systemic Lupus) (2)Metastatic Gastric Adenocarcinoma (2)Colorectal Cancer (2)Peripheral Arterial Disease (2)Intracranial Meningioma (2)Macular Degeneration (2)Stage III Pancreatic Cancer AJCC v8 (2)Stage IV Pancreatic Cancer AJCC v8 (2)Lung Cancer (2)

Frequently Asked Questions — Clinical Trials in Iowa

How many clinical trials are currently recruiting in Iowa?
ClinicalMetric currently tracks 118 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 118. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Iowa?
Iowa hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Cancer, COPD, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Iowa?
To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Iowa

NCT07572773 N/A
Recruiting
CHAMP Lung Cancer Screening Program
Condition
Lung Cancer
Enrollment
300 pts
Location
United States
Sponsor
Jill Kolesar
View Trial →
NCT07223944 Phase 3
Recruiting
A Gaucher Disease Gene Therapy Trial With FLT201
Condition
Gaucher Disease Type 1
Enrollment
45 pts
Location
United States, Argentina, Australia
Sponsor
Spur Therapeutics
View Trial →
NCT05768139 Phase 1, Phase 2
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination W...
Condition
Breast Cancer
Enrollment
880 pts
Location
United States, Belgium, France
Sponsor
Eli Lilly and Company
View Trial →
NCT06868212 Phase 3
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Time...
Condition
Chronic Spontaneous Urticaria (CSU)
Enrollment
400 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07496567 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Brazil, Colombia
Sponsor
EyeBiotech Ltd.
View Trial →
NCT07417111 N/A
Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
Condition
Bronchopulmonary Dysplasia (BPD)
Enrollment
860 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT03998202 N/A
Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal...
Condition
Colorectal Cancer
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT07609394 N/A
Recruiting
Duchenne Electronic Health Record Study
Condition
Duchenne Muscular Dystrophy (DMD)
Enrollment
2,500 pts
Location
United States
Sponsor
The Duchenne Registry
View Trial →
NCT06911372 Phase 1
Recruiting
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrova...
Condition
Gestational Diabetes Mellitus (GDM)
Enrollment
84 pts
Location
United States
Sponsor
Anna Stanhewicz, PhD
View Trial →
NCT06022939 Phase 3
Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemothera...
Condition
AL Amyloidosis
Enrollment
338 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT07222137 Phase 3
Recruiting
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in A...
Condition
Diabetes Mellitus, Type 1
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT05408845 Phase 2
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Ch...
Condition
Metastatic Salivary Gland Carcinoma
Enrollment
146 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT04924205 N/A
Recruiting
A Comparison Of Primary TKA Rehabilitation Using A Smart Orthotic Versus Outpati...
Condition
Arthropathy of Knee
Enrollment
80 pts
Location
United States
Sponsor
Nicolas Noiseux, MD, MS, FRCSC
View Trial →
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04561518 N/A
Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-M...
Condition
Transthyretin-Mediated Amyloidosis
Enrollment
1,500 pts
Location
United States, Brazil, Bulgaria
Sponsor
Alnylam Pharmaceuticals
View Trial →
Page 5 of 5 — 118 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology